Intermede Investment Partners Ltd Lowers Stock Holdings in Danaher Corporation $DHR

Intermede Investment Partners Ltd cut its holdings in shares of Danaher Corporation (NYSE:DHR) by 36.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 155,305 shares of the conglomerate’s stock after selling 88,056 shares during the quarter. Danaher comprises approximately 1.5% of Intermede Investment Partners Ltd’s portfolio, making the stock its 28th biggest holding. Intermede Investment Partners Ltd’s holdings in Danaher were worth $35,552,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Elevated Capital Advisors LLC purchased a new position in shares of Danaher during the 4th quarter worth about $26,000. JPL Wealth Management LLC acquired a new position in Danaher during the third quarter worth approximately $25,000. WFA of San Diego LLC purchased a new position in Danaher during the second quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher during the third quarter worth approximately $27,000. Finally, Capco Asset Management LLC acquired a new position in shares of Danaher in the 4th quarter valued at $34,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DHR has been the subject of several research reports. Jefferies Financial Group reissued a “buy” rating and set a $245.00 price objective on shares of Danaher in a research note on Tuesday, April 21st. Guggenheim reduced their target price on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. Argus cut their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. Finally, Barclays reduced their price objective on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Nineteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average target price of $238.65.

Danaher Stock Performance

NYSE:DHR opened at $172.12 on Monday. The firm’s fifty day simple moving average is $183.52 and its 200 day simple moving average is $208.70. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The firm has a market capitalization of $121.82 billion, a price-to-earnings ratio of 33.29, a PEG ratio of 2.30 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.88 earnings per share. As a group, equities research analysts expect that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.